Drugs / Velpatasvir/Sofosbuvir
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT04653818 Comparator | Oct 2020 → Oct 2022 | hepatitis C virus infection, hepatocellular carcinoma | Alexandria University | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Velpatasvir/Sofosbuvir | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04653818 ↗ |